Results 101 to 110 of about 85,655 (308)

Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy [PDF]

, 2017
Immune checkpoint factors, such as programmed cell death protein-1/2 (PD-1, PD-2) or cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) receptors, are targets for monoclonal antibodies (MAbs) developed for cancer immunotherapy.
Mai, Antonello, Mazzone, Roberta, Valente, Sergio, Zwergel, Clemens   +3 more
core   +1 more source

Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma

Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley   +1 more source

Assessment of Treatment Response in Patients With Scleromyxedema by the Double Modified Rodnan Skin Score

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley   +1 more source

Keratitis-ichthyosis-deafness syndrome, atypical connexin GJB2 genemutation, and peripheral T-cell lymphoma: more than a random association? [PDF]

, 2011
Keratitis-ichthyosis-deafness (KID) syndrome is a rare congenital disorder characterized by a variety of skin lesions— that is, palmoplantar keratoderma, thickening of the skin, and erythematous verrucous lesions—neurosensorial hypoacusia, and keratitis
Contini, Salvatore, Cottoni, Francesca Maria Giovanna, Cucca, Francesco, Fozza, Claudio, Galleu, Antonio, Longinotti, Maurizio Roberto, Poddie, Fausto Pier'Angelo   +6 more
core   +3 more sources

Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study

JEADV Clinical Practice, EarlyView.
This multicenter retrospective study included 29 juvenile mycosis fungoides (JMF) patients from five Italian centres with confirmed histopathological diagnosis. most often presents with hypopigmented/classic variants and CD8+ phenotype. Early‐onset cases ( < 14 years) show better long‐term outcomes.
Andrea Michelerio, Gabriele Roccuzzo, Iria Neri, Alessandro Pileri, Alessandro Svizzero, Maria Beatrice De Felici Del Giudice, Vieri Grandi, Pietro Quaglino, Valeria Brazzelli   +8 more
wiley   +1 more source

Parapsoriasis

Zdravniški Vestnik, 2014
Parapsoriasis is a dermatological term for a group of chronic erythematosquamous skin disorders, which share their clinical features and possibility of progression to cutaneous T-cell lymphoma.
Viktor Tenyi, Mateja Dolenc-Voljč
doaj  

Cutaneous primary B-cell lymphomas: from diagnosis to treatment [PDF]

, 2015
Primary cutaneous B-cell lymphomas are a heterogeneous group of mature B-cells neoplasms with tropism for the skin, whose biology and clinical course differ significantly from the equivalent nodal lymphomas.
Lima, M.
core   +3 more sources

Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover [PDF]

, 2016
Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of chronically inflamed skin lesions containing malignant T cells. Early disease presents as limited skin patches or plaques and exhibits an indolent behavior.
A Antonelli, A Ciree, A Mishra, A Pileri, A Rabenhorst, A Sors, A Ungewickell, A Vacca, A Willerslev-Olsen, A Willerslev-Olsen, A Woetmann, AC Hsi, AC Silva Almeida da, AG Bais, AH Diwan, AH Rook, AH Rook, AH Rook, Anders Woetmann, B Belloni, B Lauenborg, BO Dulmage, BR Vowels, C Brender, C Gunther, C Thode, CL Berger, CL Berger, CM Jackow, CP Tensen, D Abeni, D Lu, D Peng, E Contassot, E Guenova, E Netchiporouk, E Papadavid, EJ Kim, Erik Langhoff, F Sallusto, GS Wood, H Echchakir, H Fujita, H Ohmatsu, H Suga, H Yu, IH Pedersen, IV Litvinov, IV Litvinov, IV Litvinov, IV Litvinov, Ivan V. Litvinov, J Choi, J Richmond, JD Bouaziz, JJ Campbell, JJ Scarisbrick, JJ Scarisbrick, JS Chung, JZ Qin, K Asadullah, K Asadullah, K Asadullah, K Ferenczi, K Kantekure, K Ohta, K Subbaramaiah, K Wolk, KF Izban, KL Kopp, KL Kopp, KL Kopp, KR Suchin, L Bao, L Chen, L Fontao, L Wang, Lars Iversen, Lise M. Lindahl, LJ Geskin, LY McGirt, M Bagot, M Duvic, M Duvic, M Duvic, M Ito, M Kasprzycka, M Marzec, M Nebozhyn, M Nielsen, M Sugaya, M Sugaya, M Tosolini, M Tuzova, M Wysocka, M Wysocka, MA Ionescu, Mariusz A. Wasik, ME Kadin, MH Vermeer, ML De, MS Kester van, MT Cheah, N Accart, N Franck, N Nagarsheth, Niels Odum, Nigel P. Mongan, NS Agar, O Zoi-Toli, P Gaur, P Kalinski, PI Axelrod, Q Zhang, Q Zhang, Q Zhang, R Doom van, R Doom van, R Doom van, R Dummer, R Talpur, R Willemze, RA Wilcox, RA Wilcox, RA Wilcox, RM Abraham, RT Hoppe, S Ehrentraut, S Esmailzadeh, S Fredholm, S Furudate, S Hahtola, S Ikeda, S Munir, S Nakahata, S Samimi, SA Islam, SK Bromley, T Kakinuma, T Kallinich, T Krejsgaard, T Krejsgaard, T Krejsgaard, T Krejsgaard, T Krejsgaard, T Krejsgaard, T Miyagaki, T Miyagaki, T Miyagaki, T Miyagaki, T Miyagaki, T Nagasawa, Thorbjørn Krejsgaard, U Dobbeling, V Blaschke, V Kodelja, V Nguyen, VE Johnson, VH Sommer, VN Kristensen, W Si, WJ Woollard, X Ma, X Ni, X Ni, X Wu, Y Fujita, Y Komohara, Y Lou, Y Tokura, YB Kural, YH Kim   +171 more
core   +2 more sources

Prevalence of Colonization, Association With Disease Stage and Effect of Eradication of Staphylococcus aureus in Cutaneous T‐Cell Lymphoma: A Systematic Review and Meta‐Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous T‐cell lymphoma (CTCL) is a rare and heterogeneous group of skin‐homing lymphomas with a largely unknown pathogenesis. Staphylococcus aureus (S. aureus) colonization has been implicated in exacerbating CTCL, particularly in advanced stages. Objectives This study assessed the prevalence of S.
Ida Lind Holm, Sarah Søltoft Rasmussen, Somaia Naassan, Misbah N. Ghazanfar, Kenneth Thomsen, Rikke Bech, Lise M. Lindahl, Maria Kamstrup, Simon Francis Thomsen, Zarqa Ali   +9 more
wiley   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target [PDF]

, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy for which there is still no effective B therapy.
Abate F., Agostinelli C., Amente S., Berti E., Bertolini F., Brundu F., Cerroni L., Dellino G. I., Etebari M., Facchetti F., Falini B., Fuligni F., Indio V., Laginestra M. A., Melle F., Motta G., Orecchioni S., Paulli M., Piccioni R., Pileri A., Pileri S. A., Pimpinelli N., Rabadan R., Rossi M., Sabattini E., Sapienza M. R., Tabanelli V., Talarico G., Tarantino G., Tripodo C., Truni M.   +30 more
core   +2 more sources